HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Brief Introductory Therapy for Opioid Dependence [Phase 2]
Phase 2 trial update for Brief Introductory Therapy in opioid dependence with HIV coinfection completed.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP) [NA]
Clinical trial update on rapid HIV self-testing among men who have sex with men (eSTAMP) completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-30Clinical Trial Update: Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China [Phase 3]
Phase 3 trial update on a behavioral drug and HIV risk reduction counseling for methadone patients in China.
-
CLINICAL_TRIALS research · 2020-03-26Clinical Trial Update: Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination [Phase 1, Phase 2]
A clinical trial updating on depletion of serum amyloid P component to enhance immune response to DNA vaccination in HIV patients; phases 1 …
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: Reducing Vulnerability in the Intimate Partnerships of Female Sex Workers Sex Workers [NA]
Completed clinical trial investigating reducing vulnerability in intimate partnerships of female sex workers with focus on violence, sexual …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-03-24FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Tivicay (dolutegravir) from ViiV Healthcare Company.
-
FDA approval · 2020-03-24FDA Approved: DOVATO — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for DOVATO (dolutegravir and lamivudine) submitted by ViiV Healthcare Company.
-
FDA approval · 2020-03-24FDA Approved: TRIUMEQ — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for TRIUMEQ, a fixed-dose combination of abacavir, dolutegravir, and lamivudine, submitted by ViiV H…
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects [Phase 3]
Phase 3 trial update evaluating a tablet combining two FDA-approved antiretroviral drugs for ART-experienced HIV-1 infected subjects.
-
CLINICAL_TRIALS trial_result · 2020-03-24Clinical Trial Update: A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients [Phase 3]
Phase 3 trial update for a fixed-dose combination tablet in antiretroviral-experienced HIV patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV [Phase 3]
Phase 3 trial update on ibalizumab with optimized background regimen in patients with multi-drug resistant HIV.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection [Phase 3]
Phase 3 clinical trial update assessing safety and efficacy of the fixed-dose combination emtricitabine/tenofovir alafenamide (F/TAF) for HI…
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Effect of Gender and HIV Infection on Zidovudine and Lamivudine Pharmacokinetics [Phase 4]
Phase 4 clinical trial investigating how gender and HIV infection influence the pharmacokinetics of zidovudine and lamivudine.
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDS [NA]
Completed randomized trial examining counseling after fatigue treatment to aid return-to-work in people with HIV/AIDS.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: The Effect of Norethisterone Enanthate on Recurrent Bacterial Vaginosis [Phase 4]
Phase 4 trial update on norethisterone enanthate for recurrent bacterial vaginosis; completed study.
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients [Phase 3]
Phase III clinical trial update for Azvudine in treatment-naive HIV-infected patients.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc [Phase 1]
Phase 1 trial assessing the pharmacokinetic interaction between rifabutin and maraviroc; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: MK-8583 Single Dose Study in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8583-002) [Phase 1]
Phase 1 single-dose study of MK-8583 in HIV-1 infected participants completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: TAF for HIV-HBV With Renal Dysfunction [Phase 2]
Phase 2 clinical trial update evaluating tenofovir alafenamide (TAF) for HIV and Hepatitis B coinfection in patients with renal dysfunction …
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response [Phase 1, Phase 2]
Phase 1/2 trial evaluating mesenchymal stromal cells (MSC) in HIV-infected individuals with controlled viremia but immunological discordant …
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection [Phase 1, Phase 2]
Phase 1/2 clinical trial studying Pentasa for reducing residual systemic immune activation in treated HIV infection and gut inflammation has…
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Doravirine, Rifapentine and Isoniazid Interaction [Phase 1]
Phase 1 trial update examining interactions between doravirine, rifapentine, and isoniazid in latent tuberculosis and HIV, with results post…
-
FDA approval · 2020-03-02FDA Approved: SYMTUZA — Supplemental Application (Janssen Products LP)
FDA approved Janssen's supplemental application for Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide), resulting in …
-
FDA approval · 2020-02-28FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a generic fixed-dose combination tablet of emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) from Zydus Pharmaceuticals…
-
CLINICAL_TRIALS trial_result · 2020-02-26Clinical Trial Update: Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy [Phase 2]
Phase 2 randomized placebo-controlled trial of atorvastatin in HIV-positive patients not on antiretroviral therapy completed; results posted…